WebJul 5, 2011 · WEE1 kinase, as gatekeeper of the G 2-checkpoint arrest, holds potential as a therapeutic target to manipulate entry into mitosis of cancer cells. Compelling preclinical … WebWee1-like protein kinase is a tyrosine kinase with a key role as an inhibitory regulator of the G2/M checkpoint that precedes entry into mitosis. Abrogation of this checkpoint through Wee1 inhibition may result in increased antitumor activity of agents that cause DNA damage such as radiation therapy or some cytotoxic agents.
Combined Targeting of PARG and Wee1 Causes Decreased Cell …
WebSep 15, 2024 · Actually, WEE1, a mitotic inhibitor kinase, participates in the regulation of the DNA damage repair pathway, and its therapeutic inhibition along with chemotherapy is currently under clinical trials investigation for cancer treatment [58,59,60,61,62,63,64,65]. Furthermore, Lal et al. demonstrated the role of WEE1 as a HuR target, both in vitro ... WebJan 1, 2024 · Targeting WEE1 as a cancer therapy. Recent studies have shown that WEE1 inhibition can overcome chemotherapy resistance in the treatment of cancer cells [130], … centro artemisia analisys 1980
Targeting WEE1 Inhibits Growth of Breast Cancer Cells That Are ...
WebNational Center for Biotechnology Information WebReena Beggs, Eddy S. Yang, in Advances in Protein Chemistry and Structural Biology, 2024. 4.2 Wee1. Wee1 is a tyrosine kinase that is known to be overexpressed in many cancer types such as luminal and HER2-positive breast cancer subtypes, hepatocellular carcinomas, and glioblastomas (Iorns et al., 2009).Wee1 directly interacts with histone H2B to halt … WebJan 12, 2024 · The cell-cycle checkpoint kinase WEE1 is emerging as a therapeutic target for cancer treatment. However, how its catalytic activity is regulated remains poorly understood, and reliable biomarkers ... centro al manhal by rotana contact number